1. Home
  2. AUBN vs ICCC Comparison

AUBN vs ICCC Comparison

Compare AUBN & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auburn National Bancorporation Inc.

AUBN

Auburn National Bancorporation Inc.

N/A

Current Price

$25.45

Market Cap

88.8M

Sector

Finance

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$9.56

Market Cap

75.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUBN
ICCC
Founded
1907
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
75.8M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
AUBN
ICCC
Price
$25.45
$9.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.4K
20.1K
Earning Date
04-28-2026
05-15-2026
Dividend Yield
4.61%
N/A
EPS Growth
13.66
53.85
EPS
0.63
0.21
Revenue
$619,000.00
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$42.11
$47.10
Revenue Growth
0.81
51.64
52 Week Low
$21.60
$4.52
52 Week High
$29.00
$10.75

Technical Indicators

Market Signals
Indicator
AUBN
ICCC
Relative Strength Index (RSI) 71.26 50.90
Support Level $24.00 $9.27
Resistance Level $27.76 $10.75
Average True Range (ATR) 0.40 0.33
MACD 0.14 -0.05
Stochastic Oscillator 98.13 36.67

Price Performance

Historical Comparison
AUBN
ICCC

About AUBN Auburn National Bancorporation Inc.

Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: